Carl Zimmer

They've made a lot of progress, and a lot of that progress came with a deeper understanding of how the immune system works. So they've learned a lot of basic science along the way, and it has been delivering a lot of promise.

They've made a lot of progress, and a lot of that progress came with a deeper understanding of how the immune system works. So they've learned a lot of basic science along the way, and it has been delivering a lot of promise.

They've made a lot of progress, and a lot of that progress came with a deeper understanding of how the immune system works. So they've learned a lot of basic science along the way, and it has been delivering a lot of promise.

And that grant has just been pulled with no explanation. That research is now over. There are projects looking for antivirals for a range of different viruses that might start the next pandemic. That's been canceled too. And those scientists aren't even sure if they'll be able to write up their results. Like you may not find out what they've done. There's just too many to choose from.

And that grant has just been pulled with no explanation. That research is now over. There are projects looking for antivirals for a range of different viruses that might start the next pandemic. That's been canceled too. And those scientists aren't even sure if they'll be able to write up their results. Like you may not find out what they've done. There's just too many to choose from.

And that grant has just been pulled with no explanation. That research is now over. There are projects looking for antivirals for a range of different viruses that might start the next pandemic. That's been canceled too. And those scientists aren't even sure if they'll be able to write up their results. Like you may not find out what they've done. There's just too many to choose from.

I mean, I've been talking with a researcher who has, you know, a massive program on understanding tuberculosis and the immune system. You know, this is the most deadly infectious disease we have these days. It kills over a million people a year. His grant was canceled and honestly, he's not sure why.

I mean, I've been talking with a researcher who has, you know, a massive program on understanding tuberculosis and the immune system. You know, this is the most deadly infectious disease we have these days. It kills over a million people a year. His grant was canceled and honestly, he's not sure why.

I mean, I've been talking with a researcher who has, you know, a massive program on understanding tuberculosis and the immune system. You know, this is the most deadly infectious disease we have these days. It kills over a million people a year. His grant was canceled and honestly, he's not sure why.

This huge program that could give us new insights about tuberculosis and might eventually lead to new treatments is just gone. Just gone. So there are definitely very short-term impacts of what this administration is doing. Cutting off the supply of drugs for HIV or halting a clinical trial potentially give a treatment for cancer.

This huge program that could give us new insights about tuberculosis and might eventually lead to new treatments is just gone. Just gone. So there are definitely very short-term impacts of what this administration is doing. Cutting off the supply of drugs for HIV or halting a clinical trial potentially give a treatment for cancer.

This huge program that could give us new insights about tuberculosis and might eventually lead to new treatments is just gone. Just gone. So there are definitely very short-term impacts of what this administration is doing. Cutting off the supply of drugs for HIV or halting a clinical trial potentially give a treatment for cancer.

These people are in the middle of these trials and they're just stopping. So those are really short-term things.

These people are in the middle of these trials and they're just stopping. So those are really short-term things.

These people are in the middle of these trials and they're just stopping. So those are really short-term things.

Um, that's, that's not great business. You'd be waiting a long time for those drug companies to pick up all that basic research that governments like the United States have been covering for decades. And a lot of this stuff, you know, when it's dropped, it's really difficult to ever start it up again. You don't bounce back from this sort of, this sort of shock to the system.

Um, that's, that's not great business. You'd be waiting a long time for those drug companies to pick up all that basic research that governments like the United States have been covering for decades. And a lot of this stuff, you know, when it's dropped, it's really difficult to ever start it up again. You don't bounce back from this sort of, this sort of shock to the system.

Um, that's, that's not great business. You'd be waiting a long time for those drug companies to pick up all that basic research that governments like the United States have been covering for decades. And a lot of this stuff, you know, when it's dropped, it's really difficult to ever start it up again. You don't bounce back from this sort of, this sort of shock to the system.

You know, there was a poll that Nature did recently. They've asked hundreds of scientists about, you know, what effect all of this chaos is having on them and their thoughts about their future. And 75% of these American scientists said they have been thinking about maybe moving forward.

You know, there was a poll that Nature did recently. They've asked hundreds of scientists about, you know, what effect all of this chaos is having on them and their thoughts about their future. And 75% of these American scientists said they have been thinking about maybe moving forward.